Johnson & Johnson (JNJ) Equity Average (2009 - 2026)

Johnson & Johnson's Equity Average history runs 18 years deep, the most recent figure standing at $81.4 billion for Q1 2026.

• In Q1 2026, Equity Average rose 8.78% year-over-year to $81.4 billion; the TTM figure through Mar 2026 stood at $81.4 billion (up 8.78% YoY), while the FY2025 annual figure was $76.5 billion, up 9.1% from the prior year.
• Equity Average came in at $81.4 billion for Q1 2026 at Johnson & Johnson, up from $80.4 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $81.4 billion in Q1 2026 to a low of $69.4 billion in Q1 2024.
• A 5-year average of $74.5 billion and a median of $74.1 billion in 2022 frame the typical range for Equity Average.
• Across the five-year window, Equity Average grew 15.2% in 2022 and declined 7.53% in 2023, its largest moves.
• Johnson & Johnson's Equity Average stood at $75.5 billion in 2022, then fell by 7.26% to $70.0 billion in 2023, then grew by 1.18% to $70.8 billion in 2024, then advanced by 13.54% to $80.4 billion in 2025, then increased by 1.19% to $81.4 billion in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $81.4 billion, $80.4 billion, and $78.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison